Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.06 -0.02 (-1.90%)
As of: Oct 23, 2026 · 3:16 PM EDT

Chemomab Therapeutics (CMMB) Change in Acquisitions & Divestments (2011 - 2023)

Updated

Chemomab Therapeutics (CMMB) reported Change in Acquisitions & Divestments of $2.3 million for FY2024, down 85.5% from $15.88 million in FY2023.

Analysis

Chemomab Therapeutics (CMMB) Change in Acquisitions & Divestments (2011 - 2023) Analysis & Trends

Dating back to FY2021, Chemomab Therapeutics' Change in Acquisitions & Divestments record includes 4 years.

  • The FY2024 figure ranks as the lowest annual Change in Acquisitions & Divestments since FY2021.
  • According to Business Quant data, Change in Acquisitions & Divestments came in at $15.88 million in FY2023 (-19.0%), $19.6 million in FY2022 and -$45.95 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.61 Bn 1,101.20 Bn 19.71 Bn
2 Johnson & Johnson 635.68 Bn 555.54 Bn 17.30 Bn
3 AbbVie 506.54 Bn 479.65 Bn 12.70 Bn
4 Merck 358.37 Bn 312.75 Bn 12.21 Bn
5 Novartis Ag 292.65 Bn 256.64 Bn 11.24 Bn
6 Astrazeneca 265.69 Bn 239.37 Bn 12.86 Bn
7 Amgen 237.83 Bn 193.23 Bn 7.24 Bn
8 Gilead Sciences 195.33 Bn 169.52 Bn 6.22 Bn
9 Pfizer 171.37 Bn 118.01 Bn 10.94 Bn
10 Chemomab Therapeutics 6.76 Mn -28.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 3.99 Mn
Sep 30, 2022 6.12 Mn
Jun 30, 2011 2.06 Mn
API Access

Chemomab Therapeutics Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=CMMB&period=max&api_key=YOUR_API_KEY